Fulcrum Therapeutics News

Fulcrum Therapeutics | 8-K: Current report

May 13 07:09 ET

Fulcrum Therapeutics | DEF 14A: Definitive information statements

Apr 19 16:13 ET

Fulcrum Therapeutics | DEFA14A: Others

Apr 19 16:10 ET

Fulcrum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 17:22 ET

Fulcrum Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Feb 27 17:18 ET

Fulcrum Therapeutics | 8-K: Current report

Feb 27 07:05 ET

Fulcrum Therapeutics | 8-K: Current report

Nov 7, 2023 07:02 ET

Fulcrum Therapeutics | 8-K: Current report

Oct 2, 2023 16:01 ET

Fulcrum Therapeutics | 8-K: Current report

Aug 22, 2023 07:01 ET

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2023

Aug 3, 2023 07:05 ET

Fulcrum Therapeutics | 8-K: Current report

Jul 10, 2023 17:06 ET

Fulcrum Therapeutics | 8-K: Current report

Jun 9, 2023 16:05 ET

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

May 15, 2023 07:06 ET

Fulcrum Therapeutics | DEFA14A: Others

Apr 28, 2023 16:10 ET

Fulcrum Therapeutics | DEF 14A: Definitive proxy statements

Apr 28, 2023 16:02 ET

Fulcrum Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 18, 2023 16:05 ET

Fulcrum Therapeutics | 8-K: Current report

Apr 5, 2023 08:13 ET

Fulcrum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 9, 2023 08:27 ET

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

Mar 9, 2023 07:14 ET

Fulcrum Therapeutics | 8-K: Current report

Jan 18, 2023 17:12 ET